Amphastar Pharmaceuticals (AMPH) Depreciation & Amortization (CF) (2019 - 2024)
Amphastar Pharmaceuticals (AMPH) posted Depreciation & Amortization (CF) of $9.8 million for Q3 2024, up 1.21% on a QoQ basis from $9.7 million in Q2 2024, and up 1.81% year-over-year from $9.6 million in Q4 2023.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Depreciation & Amortization (CF) (2019 - 2024) Analysis & Trends
Amphastar Pharmaceuticals has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $9.8 million in Q3 2024.
- On a quarterly basis, Depreciation & Amortization (CF) rose 1.81% year-over-year to $9.8 million in Q3 2024; TTM through Jun 2025 was $9.8 million, a 74.64% decrease from a year earlier, with the FY2023 full-year figure at $25.7 million, up 104.31% from the prior year.
- Depreciation & Amortization (CF) was $9.8 million for Q3 2024 at Amphastar Pharmaceuticals, up from $9.7 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $9.8 million in Q3 2024, with the low at $2.0 million in Q2 2020.
- Average Depreciation & Amortization (CF) over 5 years is $4.6 million, with a median of $3.0 million recorded in 2022.
- The largest YoY upside for Depreciation & Amortization (CF) was 215.9% in 2024 against a maximum downside of 1.81% in 2024.
- Over 5 years, Depreciation & Amortization (CF) stood at $2.5 million in 2020, then climbed by 3.96% to $2.6 million in 2021, then jumped by 32.28% to $3.4 million in 2022, then jumped by 180.86% to $9.7 million in 2023, then climbed by 1.42% to $9.8 million in 2024.
- The last three Depreciation & Amortization (CF) figures came in at $9.8 million (Q3 2024), $9.7 million (Q2 2024), and $9.7 million (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 241.00 Mn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 672.30 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 56.74 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 281.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 19.64 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 10.33 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | - |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | 33,326.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 9.79 Mn |
| Jun 30, 2024 | 9.68 Mn |
| Mar 31, 2024 | 9.66 Mn |
| Dec 31, 2023 | 9.66 Mn |
| Sep 30, 2023 | 9.62 Mn |
| Jun 30, 2023 | 3.06 Mn |
| Mar 31, 2023 | 3.40 Mn |
| Dec 31, 2022 | 3.44 Mn |
| Sep 30, 2022 | 3.42 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 2.74 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 2.50 Mn |
| Jun 30, 2021 | 2.64 Mn |
| Mar 31, 2021 | 2.48 Mn |
| Dec 31, 2020 | 2.50 Mn |
| Sep 30, 2020 | 2.46 Mn |
| Jun 30, 2020 | 2.03 Mn |
| Mar 31, 2020 | 2.05 Mn |
| Dec 31, 2019 | 2.07 Mn |
API Access
Amphastar Pharmaceuticals Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();